Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology

to the Middle East and North Africa Amman, Jordan Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive agreement with Guardant Health, Inc., a leading precision oncology company. Through the agreement, Hikma has the exclusive rights for commercialisation and marketing of Guardant Health’s portfolio of liquid and tissueContinue Reading